The Enhanced Liver Fibrosis (ELF) score: normal values, influence factors and proposed cut-off values.
暂无分享,去创建一个
Korbinian Brand | Ralf Lichtinghagen | M. Manns | R. Lichtinghagen | K. Brand | M. Bahr | H. Bantel | Michael P Manns | Daniel Pietsch | Heike Bantel | Matthias J Bahr | Daniel Pietsch
[1] Llorenç Quintó,et al. Identification of chronic hepatitis C patients without hepatic fibrosis by a simple predictive model , 2002, Hepatology.
[2] R. Testa,et al. Noninvasive diagnosis of fibrosis: The truth is rarely pure and never simple , 2003, Hepatology.
[3] S. Friedman,et al. Pathogenesis of liver fibrosis. , 2011, Annual review of pathology.
[4] W. Rosenberg,et al. Performance of ELF serum markers in predicting fibrosis stage in pediatric non-alcoholic fatty liver disease. , 2009, Gastroenterology.
[5] J. Kalbfleisch,et al. A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C , 2003, Hepatology.
[6] J. Talwalkar,et al. Noninvasive assessment of liver fibrosis , 2011, Hepatology.
[7] Rosa Gilabert,et al. ARFI, FibroScan, ELF, and their combinations in the assessment of liver fibrosis: a prospective study. , 2012, Journal of hepatology.
[8] P. Bedossa,et al. Intraobserver and Interobserver Variations in Liver Biopsy Interpretation in Patients with Chronic Hepatitis C , 1994 .
[9] P. Bedossa,et al. Fibrosis in Patients with Chronic Hepatitis C: Detection and Significance , 2000, Seminars in liver disease.
[10] Neil Kaplowitz,et al. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis , 1981, Hepatology.
[11] G. Ramadori,et al. Mesenchymal cells in the liver--one cell type or two? , 2002, Liver.
[12] Heather Fry,et al. A user’s guide , 2003 .
[13] K. Ishak,et al. Histological grading and staging of chronic hepatitis. , 1995 .
[14] M. Manns,et al. Biopsy-Controlled Liver Fibrosis Staging Using the Enhanced Liver Fibrosis (ELF) Score Compared to Transient Elastography , 2012, PloS one.
[15] A. West,et al. Prediction of clinical outcomes in primary biliary cirrhosis by serum enhanced liver fibrosis assay , 2008, Hepatology.
[16] T. Poynard,et al. Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study , 2001, The Lancet.
[17] G. Alexander,et al. Enhanced liver fibrosis test can predict clinical outcomes in patients with chronic liver disease , 2010, Gut.
[18] Samer S El-Kamary,et al. Role of liver biopsy in management of chronic hepatitis C: A systematic review , 2002, Hepatology.
[19] J. Sninsky,et al. Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis C patients with minimal liver disease. , 2009, Journal of hepatology.
[20] R. Lichtinghagen,et al. Noninvasive diagnosis of fibrosis in chronic liver disease , 2004, Expert review of molecular diagnostics.
[21] I. Guha,et al. Noninvasive markers of fibrosis in nonalcoholic fatty liver disease: Validating the European Liver Fibrosis Panel and exploring simple markers , 2007, Hepatology.
[22] J C Boyd,et al. On dividing reference data into subgroups to produce separate reference ranges. , 1990, Clinical chemistry.
[23] A. Baranova,et al. Non-Invasive markers for hepatic fibrosis , 2011, BMC gastroenterology.
[24] Herrine,et al. Schiff's diseases of the liver , 1999, Gastroenterology.
[25] P. Scheuer,et al. Classification of chronic viral hepatitis: a need for reassessment. , 1991, Journal of hepatology.
[26] X. Forns,et al. Assessment of liver fibrosis before and after antiviral therapy by different serum marker panels in patients with chronic hepatitis C , 2011, Alimentary pharmacology & therapeutics.
[27] Laurent Castera,et al. Noninvasive methods to assess liver disease in patients with hepatitis B or C. , 2012, Gastroenterology.
[28] D. Schuppan,et al. Serum markers detect the presence of liver fibrosis: a cohort study. , 2004, Gastroenterology.